StemCells Financial Market Data
| Last Close 08-Sep-2008 |
$1.16 |
Price/ Sales Ratio |
1,041.22 |
| 52-Week High |
$2.53 |
Price/ Book Ratio |
4.13 |
| 52-Week Low |
$1.00 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
2.0 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$93.8 |
Return on Assets |
(60.9%) |
| Shares Outstanding (mil.) |
80.9 |
Return on Equity |
(80.5%) |
| Dividend Rate |
-- |
Current Ratio |
5.58 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.05 |
| # of Institutional Holders |
45 |
% Owned by Institutions |
8.0% |
| Latest Short Interest Ratio |
7.27 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
102.3% |
(21.1%) |
(69.8%) |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
